Scynexis Inc
SCYX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178253
No open-market purchases or sales by Scynexis Inc insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Scynexis Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 40 | 1 | 39 | 0 |
| Shares | 11.6M | 4.00K | 11.1M | −498.4K (−4.3%) |
| Value | $11.0M | $3.81K | $7.49M | −$3.55M (−32.2%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Scynexis Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 53,507 | $36.0K | 0.00% |
| Jane Street Group, LLC | 39,496 | $26.7K | 0.00% |
| Tower Research Capital LLC (TRC) | 6,150 | $4.15K | 0.00% |
| Atlantic Union Bankshares Corp | 4,000 | $2.70K | 0.00% |
| Simplex Trading, LLC | 1,967 | $1.00K | 0.00% |
| FMR LLC | 1,400 | $945 | 0.00% |
Sold out (6)
Institutions that held Scynexis Inc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Citadel Advisors LLC | 72,357 | $68.9K |
| Squarepoint Ops LLC | 37,127 | $35.3K |
| PDS Planning, Inc | 15,000 | $14.3K |
| Park Avenue Securities LLC | 14,000 | $13.0K |
| Royal Bank of Canada | 1,000 | $1.00K |
| JPMorgan Chase & Co | 77 | $73 |
Not filed for Q2 2025 yet (1)
Institutions that held Scynexis Inc at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Sandy Spring Bank | 4,000 | $3.81K |